Skip Nav Destination
Abstract CT091: Safety and pharmacodynamic activity of MEDI9197, a TLR 7/8 agonist, administered intratumorally in subjects with solid tumors
Cancer Res (2017) 77 (13_Supplement): CT091.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Joshua D. Bernstock
- Kyung-Don Kang
- Neil V. Klinger
- Hannah E. Olsen
- Sam Gary
- Stacie K. Totsch
- Gelare Ghajar-Rahimi
- David Segar
- Eric M. Thompson
- Victor Darley-Usmar
- Bryan T. Mott
- Luca Peruzzotti-Jametti
- Gregory K. Friedman
Oncogene (2022) 41 (19): 2663.
- Sachin Bhagchandani
- Jeremiah A. Johnson
- Darrell J. Irvine
Advanced Drug Delivery Reviews (2021) 175: 113803.
- Farrukh Vohidov
- Lauren E. Milling
- Qixian Chen
- Wenxu Zhang
- Sachin Bhagchandani
- Hung V.-T. Nguyen
- Darrell J. Irvine
- Jeremiah A. Johnson
Chemical Science (2020) 11 (23): 5974.
- Ling Bai
- Wenqian Li
- Weijia Zheng
- Dongsheng Xu
- Naifei Chen
- Jiuwei Cui
Pharmacological Research (2020) 159: 105017.
- Mark Aleynick
- Judit Svensson-Arvelund
- Christopher R. Flowers
- Aurélien Marabelle
- Joshua D. Brody
Clinical Cancer Research (2019) 25 (21): 6283.
- Alvaro H Ingles Garces
- Lewis Au
- Robert Mason
- Jennifer Thomas
- James Larkin
Expert Opinion on Investigational Drugs (2019) 28 (8): 695.
- Julian A. Marin-Acevedo
- Aixa E. Soyano
- Bhagirathbhai Dholaria
- Keith L. Knutson
- Yanyan Lou
Journal of Hematology & Oncology (2018) 11 (1)
- Julian A. Marin-Acevedo
- Bhagirathbhai Dholaria
- Aixa E. Soyano
- Keith L. Knutson
- Saranya Chumsri
- Yanyan Lou
Journal of Hematology & Oncology (2018) 11 (1)
- Robert W. Wilkinson
- Andrew J. Leishman
Frontiers in Immunology (2018) 9
